Using the Kaplan–Meier plotter and establishing the median as cut-off, we found that NSCLC patients with low SCARA5 and AOX1 mRNA levels had a significantly shorter RFS and OS than those with high levels (Fig. 6B, C). This evidence concerns the gene AOX1 and non-small cell lung carcinoma.